Accuray (ARAY) Set to Announce Earnings on Tuesday

Share on StockTwits

Accuray (NASDAQ:ARAY) will be posting its quarterly earnings results after the market closes on Tuesday, April 23rd. Analysts expect Accuray to post earnings of ($0.04) per share for the quarter. Accuray has set its FY 2019 guidance at EPS.

Accuray (NASDAQ:ARAY) last announced its quarterly earnings results on Tuesday, January 22nd. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.03. Accuray had a negative net margin of 5.74% and a negative return on equity of 42.74%. The firm had revenue of $102.32 million for the quarter, compared to analyst estimates of $104.01 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. On average, analysts expect Accuray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of ARAY opened at $4.27 on Tuesday. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.00 and a current ratio of 1.71. Accuray has a twelve month low of $3.16 and a twelve month high of $5.40. The company has a market capitalization of $386.67 million, a price-to-earnings ratio of -15.25 and a beta of 2.07.

A number of research analysts have weighed in on the stock. Zacks Investment Research lowered shares of Accuray from a “buy” rating to a “hold” rating in a research note on Wednesday, January 2nd. BidaskClub raised shares of Accuray from a “sell” rating to a “hold” rating in a research note on Thursday, February 7th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $5.13.

In other Accuray news, CEO Joshua Levine sold 6,604 shares of Accuray stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $4.54, for a total value of $29,982.16. Following the transaction, the chief executive officer now owns 1,033,593 shares of the company’s stock, valued at $4,692,512.22. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.40% of the company’s stock.

A hedge fund recently raised its stake in Accuray stock. Geode Capital Management LLC lifted its holdings in Accuray Incorporated (NASDAQ:ARAY) by 14.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 992,090 shares of the medical equipment provider’s stock after purchasing an additional 126,656 shares during the quarter. Geode Capital Management LLC owned 1.13% of Accuray worth $3,382,000 as of its most recent SEC filing. Institutional investors and hedge funds own 80.24% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Accuray (ARAY) Set to Announce Earnings on Tuesday” was originally reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4295716/accuray-aray-set-to-announce-earnings-on-tuesday.html.

About Accuray

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.

Featured Article: Derivative

Earnings History for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Maker  Market Cap Reaches $680.31 Million
Maker Market Cap Reaches $680.31 Million
Zacks: Liberty Braves Group Series A  Given $43.00 Average Price Target by Brokerages
Zacks: Liberty Braves Group Series A Given $43.00 Average Price Target by Brokerages
Peony  Reaches Market Cap of $4,449.00
Peony Reaches Market Cap of $4,449.00
Zacks: Brokerages Expect Schneider National Inc  Will Announce Quarterly Sales of $1.30 Billion
Zacks: Brokerages Expect Schneider National Inc Will Announce Quarterly Sales of $1.30 Billion
imbrex Hits 1-Day Volume of $204.00
imbrex Hits 1-Day Volume of $204.00
Electroneum  Trading 10.8% Higher  Over Last Week
Electroneum Trading 10.8% Higher Over Last Week


© 2006-2019 Ticker Report